Follow the evidence
Read the original report, then compare company disclosures and the relevant official data. A headline alone does not establish an effect on markets.
J&J in talks to buy eye disease biotech Ollin for $3.4 bln, FT reports
Read original reporting ↗This page preserves an attributed headline and brief excerpt. The publisher maintains the original report and any subsequent corrections. Report a classification or link issue →